Lee Pickering

Title: Lee Pickering: Innovator in Nucleotide Analogues

Introduction

Lee Pickering is a notable inventor based in Amersham, GB. She has made significant contributions to the field of biotechnology, particularly in the development of nucleotide analogues. Her innovative work has led to the filing of a patent that showcases her expertise and creativity in this specialized area.

Latest Patents

Lee Pickering holds a patent for "Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety." This patent describes nucleotides that include a reporter moiety which does not also function as a polymerase enzyme blocking moiety. The patent further details compounds of Formula (I), where W represents a phosphate group, B is a base, and Y is a linker that includes an enzyme-cleavable group. The reporter moiety, R, can be selected from H or OH, while Z and Z' can be chosen from H, OH, or a group X—R, with specific conditions regarding the polymerase enzyme blocking group.

Career Highlights

Lee Pickering is currently associated with GE Healthcare UK Limited, where she continues to push the boundaries of innovation in her field. Her work has been instrumental in advancing the understanding and application of nucleotide analogues in various biotechnological processes.

Collaborations

Throughout her career, Lee has collaborated with esteemed colleagues such as Raj Odedra and Adrian Christopher Simmonds. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.

Conclusion

Lee Pickering's contributions to the field of biotechnology, particularly through her patent on nucleotide analogues, highlight her role as an influential inventor. Her work continues to inspire advancements in the industry and showcases the importance of innovation in scientific research.